Testing, Reporting & Lab Information
ShareCompartir
These documents provide guidance for clinicians and public health professionals in the United States on appropriate testing, specimen collection and processing for patients who may be infected with avian influenza viruses.
Guidance Documents
- Specimen Collection and Testing for Patients with Novel Influenza A Viruses with Potential to Cause Severe Disease in Humans
- Specimen Collection and Testing for Patients with Novel Influenza A Viruses Associated with Severe Disease in Humans
- Diagnostics for Detecting H7N9 Using rRT-PCR
- CDC and USDA: Interim Risk Assessment and Biosafety Level Recommendations for Working with Influenza A (H7N9) Viruses
- Page last reviewed: April 6, 2017
- Page last updated: April 6, 2017
- Content source:
- Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)
- Page maintained by: Office of the Associate Director for Communication, Digital Media Branch, Division of Public Affairs